Published in Mol Cell Neurosci on March 01, 1996
BDNF and activity-dependent synaptic modulation. Learn Mem (2003) 4.04
Synaptic secretion of BDNF after high-frequency stimulation of glutamatergic synapses. EMBO J (2001) 2.38
Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice. Proc Natl Acad Sci U S A (1996) 2.10
Induction of long-term potentiation and depression is reflected by corresponding changes in secretion of endogenous brain-derived neurotrophic factor. Proc Natl Acad Sci U S A (2004) 1.76
Acute and gradual increases in BDNF concentration elicit distinct signaling and functions in neurons. Nat Neurosci (2010) 1.68
BDNF and its pro-peptide are stored in presynaptic dense core vesicles in brain neurons. J Cell Biol (2012) 1.65
Role of the brain-derived neurotrophic factor at glutamatergic synapses. Br J Pharmacol (2007) 1.64
Neurotrophin release by neurotrophins: implications for activity-dependent neuronal plasticity. Proc Natl Acad Sci U S A (1997) 1.55
Neurotrophin secretion from hippocampal neurons evoked by long-term-potentiation-inducing electrical stimulation patterns. Proc Natl Acad Sci U S A (2002) 1.53
The lighter side of BDNF. Am J Physiol Regul Integr Comp Physiol (2011) 1.38
Activity- and Ca(2+)-dependent modulation of surface expression of brain-derived neurotrophic factor receptors in hippocampal neurons. J Cell Biol (2000) 1.37
Activity-dependent scaling of GABAergic synapse strength is regulated by brain-derived neurotrophic factor. Mol Cell Neurosci (2005) 1.30
Self-amplifying autocrine actions of BDNF in axon development. Proc Natl Acad Sci U S A (2011) 1.25
Difference in trafficking of brain-derived neurotrophic factor between axons and dendrites of cortical neurons, revealed by live-cell imaging. BMC Neurosci (2005) 1.24
Activity-dependent dendritic release of BDNF and biological consequences. Mol Neurobiol (2009) 1.24
The effects of aerobic activity on brain structure. Front Psychol (2012) 1.16
Regulation of TrkB receptor tyrosine kinase and its internalization by neuronal activity and Ca2+ influx. J Cell Biol (2003) 1.16
Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease. Brain Res (2005) 1.15
A bi-directional carboxypeptidase E-driven transport mechanism controls BDNF vesicle homeostasis in hippocampal neurons. Mol Cell Neurosci (2008) 1.15
Signaling mechanisms mediating BDNF modulation of synaptic plasticity in the hippocampus. Learn Mem (1999) 1.14
The neuroprotective roles of BDNF in hypoxic ischemic brain injury. Biomed Rep (2012) 1.11
Neurotrophins induce release of neurotrophins by the regulated secretory pathway. Proc Natl Acad Sci U S A (1998) 1.11
Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction. Nat Commun (2013) 1.10
Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology (Berl) (2006) 1.09
Running exercise-induced up-regulation of hippocampal brain-derived neurotrophic factor is CREB-dependent. Hippocampus (2009) 1.09
Presynaptic BDNF promotes postsynaptic long-term potentiation in the dorsal striatum. J Neurosci (2010) 1.08
Retrograde signaling at central synapses. Proc Natl Acad Sci U S A (2001) 1.08
Status epilepticus-induced somatostatinergic hilar interneuron degeneration is regulated by striatal enriched protein tyrosine phosphatase. J Neurosci (2007) 1.07
Gene Transfer of Brain-derived Neurotrophic Factor (BDNF) Prevents Neurodegeneration Triggered by FXN Deficiency. Mol Ther (2016) 1.06
Brain-derived neurotrophic factor attenuates mouse cerebellar granule cell GABA(A) receptor-mediated responses via postsynaptic mechanisms. J Physiol (2003) 1.03
Synaptic reliability correlates with reduced susceptibility to synaptic potentiation by brain-derived neurotrophic factor. Learn Mem (1999) 1.03
Nitric oxide down-regulates brain-derived neurotrophic factor secretion in cultured hippocampal neurons. Proc Natl Acad Sci U S A (2002) 1.02
The neurotrophins and their role in Alzheimer's disease. Curr Neuropharmacol (2011) 0.98
Correlated network activity enhances synaptic efficacy via BDNF and the ERK pathway at immature CA3 CA1 connections in the hippocampus. Proc Natl Acad Sci U S A (2007) 0.97
Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release. J Biol Chem (2009) 0.96
Activity-dependent activation of TrkB neurotrophin receptors in the adult CNS. Learn Mem (1999) 0.95
BDNF-TrkB signaling pathway mediates the induction of epileptiform activity induced by a convulsant drug cyclothiazide. Neuropharmacology (2009) 0.95
Blockade of NR2B-containing NMDA receptors prevents BDNF enhancement of glutamatergic transmission in hippocampal neurons. Learn Mem (1999) 0.93
New insight in expression, transport, and secretion of brain-derived neurotrophic factor: Implications in brain-related diseases. World J Biol Chem (2014) 0.93
Gene-experience interaction alters the cholinergic septohippocampal pathway of mice. Proc Natl Acad Sci U S A (2000) 0.92
BDNF modulation of NMDA receptors is activity dependent. J Neurophysiol (2008) 0.91
Regulated release of BDNF by cortical oligodendrocytes is mediated through metabotropic glutamate receptors and the PLC pathway. ASN Neuro (2009) 0.90
An overview of brain-derived neurotrophic factor and implications for excitotoxic vulnerability in the hippocampus. Int J Pept (2011) 0.88
Precursor of brain-derived neurotrophic factor (proBDNF) forms a complex with Huntingtin-associated protein-1 (HAP1) and sortilin that modulates proBDNF trafficking, degradation, and processing. J Biol Chem (2011) 0.86
Tyrosine phosphatase SHP-2 is a mediator of activity-dependent neuronal excitotoxicity. EMBO J (2005) 0.85
Up-regulation of brain-derived neurotrophic factor by application of fibroblast growth factor-2 to the cut optic nerve is important for long-term survival of retinal ganglion cells. J Neurosci Res (2008) 0.81
TrkB-like immunoreactivity is present on geniculocortical afferents in layer IV of kitten primary visual cortex. J Comp Neurol (2001) 0.80
Neuronal profilin isoforms are addressed by different signalling pathways. PLoS One (2012) 0.80
Enhanced extinction of cocaine seeking in brain-derived neurotrophic factor Val66Met knock-in mice. Eur J Neurosci (2012) 0.80
Signaling pathways regulating cell motility: a role in ethanol teratogenicity? Alcohol Clin Exp Res (2006) 0.79
BDNF Induces Striatal-Enriched Protein Tyrosine Phosphatase 61 Degradation Through the Proteasome. Mol Neurobiol (2015) 0.78
Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia. Psychol Med (2014) 0.76
BDNF-induced presynaptic facilitation of GABAergic transmission in the hippocampus of young adults is dependent of TrkB and adenosine A2A receptors. Purinergic Signal (2016) 0.76
The Contribution of Spatial and Temporal Molecular Networks in the Induction of Long-term Memory and Its Underlying Synaptic Plasticity. AIMS Neurosci (2016) 0.75
Differential regulation of NMDA receptors by d-serine and glycine in mammalian spinal locomotor networks. J Neurophysiol (2017) 0.75
Microencapsulated islets as bioartificial endocrine pancreas. Science (1980) 4.35
Regulation of neuronal traits by a novel transcriptional complex. Neuron (2001) 4.02
Characterization of a multicomponent receptor for GDNF. Nature (1996) 2.92
Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science (1998) 2.83
Conventional tissue culture compared with rapid immunofluorescence for identifying Chlamydia trachomatis in specimens from patients attending a genitourinary clinic. Genitourin Med (1985) 2.54
Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science (1989) 2.46
Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology (2011) 2.42
Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci (1986) 2.33
Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron (1995) 2.19
A UGA termination suppression tRNATrp active in rabbit reticulocytes. Nature (1980) 2.10
High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy. Eur J Clin Invest (2008) 2.05
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Res (1999) 2.02
Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science (1994) 1.98
Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J Virol (1996) 1.89
Failure of parenteral metronidazole in the treatment of pseudomembranous colitis. J Infect Dis (1988) 1.79
Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature (1995) 1.79
NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain? Brain Res (1983) 1.77
Rab17 regulates membrane trafficking through apical recycling endosomes in polarized epithelial cells. J Cell Biol (1998) 1.74
Hypoxia-inducible factor-1alpha mediates hypoxia-induced delayed neuronal death that involves p53. J Neurosci (1999) 1.67
Purification and characterization of an alpha-glucosidase from Saccharomyces carlsbergensis. Biochemistry (1978) 1.67
Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207). FASEB J (1999) 1.64
Isolation of a maltase structural gene from Saccharomyces carlsbergensis. J Bacteriol (1982) 1.60
Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension (1990) 1.58
First symptom in sporadic Creutzfeldt-Jakob disease. Neurology (2006) 1.58
Reduced water and sodium intakes associated with high levels of natriuretic factor following common bile duct ligation in the rabbit. Br J Surg (1990) 1.57
Modulation of the neuronal glutamate transporter EAAT4 by two interacting proteins. Nature (2001) 1.53
Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc Natl Acad Sci U S A (1991) 1.52
Foot-and-mouth disease virus lacking the VP1 G-H loop: the mutant spectrum uncovers interactions among antigenic sites for fitness gain. Virology (2001) 1.50
K-252 compounds: modulators of neurotrophin signal transduction. J Neurochem (1992) 1.49
Periarticular ankle sarcoidosis: a variant of Löfgren's syndrome. J Rheumatol (1996) 1.49
Complementation of RNA binding site mutations in MS2 coat protein heterodimers. Nucleic Acids Res (1996) 1.47
Usefulness of bone densitometry in postmenopausal women with clinically diagnosed vertebral fractures. Ann Rheum Dis (2002) 1.43
Effects of chronic therapy with cilazapril, a new angiotensin-converting enzyme inhibitor, on regional blood flows in conscious spontaneously hypertensive rats. J Cardiovasc Pharmacol (1987) 1.40
Treatment approaches for congenital pseudarthrosis of tibia: results of the EPOS multicenter study. European Paediatric Orthopaedic Society (EPOS). J Pediatr Orthop B (2000) 1.38
Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med (1995) 1.36
The influence of heregulins on human Schwann cell proliferation. J Neurosci (1995) 1.34
Precursor control of neurotransmitter synthesis. Pharmacol Rev (1980) 1.34
Carbon catabolite repression of maltase synthesis in Saccharomyces carlsbergensis. J Bacteriol (1983) 1.33
Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain (2008) 1.30
Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells. Biotechniques (1996) 1.28
HIF-1alpha and p53 promote hypoxia-induced delayed neuronal death in models of CNS ischemia. Exp Neurol (1999) 1.28
Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res (1980) 1.27
Regulated neurotrophin receptor responsiveness during neuronal migrationand early differentiation. J Neurosci (1994) 1.23
Expression of nerve growth factor in vivo from a defective herpes simplex virus 1 vector prevents effects of axotomy on sympathetic ganglia. Proc Natl Acad Sci U S A (1992) 1.21
Nerve growth factor increases choline acetyltransferase but not survival or fiber outgrowth of cultured fetal septal cholinergic neurons. Neuroscience (1985) 1.21
Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke (1995) 1.20
Synovial sarcomas usually metastasize after >5 years: a multicenter retrospective analysis with minimum follow-up of 10 years for survivors. Ann Oncol (2010) 1.19
Synapsin I Cre transgene expression in male mice produces germline recombination in progeny. Genesis (2006) 1.18
A method to codetect introduced genes and their products in gene therapy protocols. Nat Biotechnol (1996) 1.16
Chronic intraventricular injections of nerve growth factor elevate hippocampal choline acetyltransferase activity in adult rats with partial septo-hippocampal lesions. Brain Res (1984) 1.16
Discoid lateral meniscus in children. Long-term follow-up after total meniscectomy. J Bone Joint Surg Am (1998) 1.16
Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology (Oxford) (2005) 1.15
Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasia of ectopic cells. Dev Biol (1995) 1.15
Cloning of AL-1, a ligand for an Eph-related tyrosine kinase receptor involved in axon bundle formation. Neuron (1995) 1.15
Cell surface proteins of chicken hematopoietic progenitors, thrombocytes and eosinophils detected by novel monoclonal antibodies. Leukemia (1992) 1.13
Functional interaction between fluorodeoxyuridine-induced cellular alterations and replication of a ribonucleotide reductase-negative herpes simplex virus. J Virol (2001) 1.12
Reconstruction with non-vascularised fibular grafts after resection of bone tumours. J Bone Joint Surg Br (2007) 1.12
A tyrosine hydroxylase-neurofilament chimeric promoter enhances long-term expression in rat forebrain neurons from helper virus-free HSV-1 vectors. Brain Res Mol Brain Res (2000) 1.12
Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism. Neurology (1981) 1.11
Effect of polyol molecular weight on the physical properties and haemocompatibility of polyurethanes containing polyethylene oxide macroglycols. Biomaterials (1994) 1.11
Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation. Neuroscience (2005) 1.10
Development of septal cholinergic neurons in culture: plating density and glial cells modulate effects of NGF on survival, fiber growth, and expression of transmitter-specific enzymes. J Neurosci (1988) 1.10
Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea. J Clin Endocrinol Metab (1990) 1.07
An HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. J Neurochem (1997) 1.07
Brucellar spondylitis: a detailed analysis based on current findings. Rev Infect Dis (1985) 1.07
Gene transfer into the nervous system. Mol Neurobiol (1987) 1.07
Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers. Gene Ther (2001) 1.06
Prolonged in vivo gene expression driven by a tyrosine hydroxylase promoter in a defective herpes simplex virus amplicon vector. Hum Gene Ther (1996) 1.05
Nonaminergic striatal neurons convert exogenous L-dopa to dopamine in parkinsonism. Ann Neurol (1980) 1.05
Löfgren's syndrome revisited: a study of 186 patients. Am J Med (1999) 1.05
Long-term expression in sensory neurons in tissue culture from herpes simplex virus type 1 (HSV-1) promoters in an HSV-1-derived vector. J Virol (1995) 1.05
Cilazapril prevents hypertension in spontaneously hypertensive rats. J Cardiovasc Pharmacol (1986) 1.05
Nerve growth factor somatic mosaicism produced by herpes virus-directed expression of cre recombinase. Nat Biotechnol (1997) 1.05
Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition. Hypertension (1991) 1.04
Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci (1992) 1.04
Diverse stabilities of expression in the rat brain from different cellular promoters in a helper virus-free herpes simplex virus type 1 vector system. Hum Gene Ther (1999) 1.04
HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding. J Neurosci (1993) 1.04
Enhanced reporter gene expression in the rat brain from helper virus-free HSV-1 vectors packaged in the presence of specific mutated HSV-1 proteins that affect the virion. Brain Res Mol Brain Res (2001) 1.03
Myb protein binds to multiple sites in the human T cell lymphotropic virus type 1 long terminal repeat and transactivates LTR-mediated expression. Virology (1992) 1.02
Regulation of maltase synthesis in Saccharomyces carlsbergensis. J Bacteriol (1983) 1.02
Discordance between expression and genome transfer titering of HSV amplicon vectors: recommendation for standardized enumeration. Mol Ther (2000) 1.01
Systemic interleukin-1 beta decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation. Neuroscience (1993) 1.01
Is Alzheimer disease caused by lack of nerve growth factor? Ann Neurol (1983) 1.00
BDNF and NGF treatment in lesioned rats: effects on cholinergic function and weight gain. Neuroreport (1992) 1.00
Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207). Hum Gene Ther (1999) 1.00
Nerve growth factor and Alzheimer's disease. Ann Neurol (1986) 1.00
The inhibition of phosphatidylinositol-3-kinase induces neurite retraction and activates GSK3. J Neurochem (2001) 0.99
Rescue of lesioned septal cholinergic neurons by nerve growth factor: specificity and requirement for chronic treatment. J Neurosci (1988) 0.99
The site of dopamine formation in rat striatum after L-dopa administration. J Pharmacol Exp Ther (1981) 0.99
Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res (1990) 0.99
Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain. Neurosci Lett (1986) 0.98